Advertisement
Advertisement
U.S. markets open in 7 hours 14 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
624.83-11.51 (-1.81%)
At close: 04:00PM EDT
623.10 -1.73 (-0.28%)
After hours: 07:52PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Benzinga

    Amgen Moves to Dismiss Regeneron's Antitrust Case Regarding Cholesterol Drug

    Since their PCSK9 drugs to lower bad cholesterol won FDA approvals in 2015, Amgen Inc (NASDAQ: AMGN) sued Regeneron Pharmaceuticals Inc (NASDAQ: REGN) regarding intellectual property in crafting an antibody that blocks the protein PCSK9 that helps the body clear LDL cholesterol. Drugs in the lawsuit are Regeneron's Praluent (alirocumab) and Amgen's Repatha (evolocumab). In May, Regeneron filed an antitrust suit that alleged Amgen conducted a bundling scheme that allowed the company to charge low

  • Insider Monkey

    10 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill

    In this article, we will be taking a look at 10 healthcare stocks to watch amid Senate’s healthcare bill. To skip our detailed analysis of these stocks and how they will be impacted by the new laws, you can go directly to see the 5 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill. On August 7, […]

  • Simply Wall St.

    Is Regeneron Pharmaceuticals (NASDAQ:REGN) Using Too Much Debt?

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Advertisement
Advertisement